Literature DB >> 18348463

P53 protein and pathogenesis of melanoma and nonmelanoma skin cancer.

Cara L Benjamin1, Vladislava O Melnikova, Honnavara N Ananthaswamy.   

Abstract

The p53 tumor suppressor gene and gene product are among the most diverse and complex been shown to have a direct correlation with cancer development and have been shown to occur in nearly 50% of all cancers. p53 mutations are particularly common in skin cancers and UV irradiation has been shown to be a primary cause of specific 'signature' mutations that can result in oncogenic transformation. There are certain 'hot-spots' in the p53 gene where mutations are commonly found that result in a mutated dipyrimidine site. This review discusses the role of p53 from normal function and its dysfunction in precancerous lesions, nonmelanoma and melanoma skin cancers. Additionally, molecules that associate with p53 and alter its function to produce neoplastic conditions are also explored in this chapter.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18348463     DOI: 10.1007/978-0-387-77574-6_21

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  21 in total

1.  In vivo siRNA targeting of CD28 reduces UV-induced DNA damage and inflammation.

Authors:  Tej Pratap Singh; Gerlinde Mayer; Peter Wolf
Journal:  J Invest Dermatol       Date:  2013-09-16       Impact factor: 8.551

2.  Over-expression of Gadd45a enhances radiotherapy efficacy in human Tca8113 cell line.

Authors:  Xiao-ying Zhang; Xun Qu; Cheng-qin Wang; Cheng-jun Zhou; Gui-xiang Liu; Feng-cai Wei; Shan-zhen Sun
Journal:  Acta Pharmacol Sin       Date:  2011-02       Impact factor: 6.150

3.  The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management.

Authors:  Keith Duffy; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2012-07       Impact factor: 11.527

Review 4.  Phytochemicals for the Management of Melanoma.

Authors:  Harish Chandra Pal; Katherine Marchiony Hunt; Ariana Diamond; Craig A Elmets; Farrukh Afaq
Journal:  Mini Rev Med Chem       Date:  2016       Impact factor: 3.862

5.  Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis.

Authors:  Noa Rivlin; Ran Brosh; Moshe Oren; Varda Rotter
Journal:  Genes Cancer       Date:  2011-04

6.  Chromosomal aberrations in UVB-induced tumors of immunosuppressed mice.

Authors:  Amy M Dworkin; Kathleen L Tober; F Jason Duncan; Lianbo Yu; Anne M VanBuskirk; Tatiana M Oberyszyn; Amanda Ewart Toland
Journal:  Genes Chromosomes Cancer       Date:  2009-06       Impact factor: 5.006

7.  High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients.

Authors:  M Reuschenbach; T Tran; F Faulstich; W Hartschuh; S Vinokurova; M Kloor; E Krautkrämer; M Zeier; M von Knebel Doeberitz; C Sommerer
Journal:  Br J Cancer       Date:  2011-03-22       Impact factor: 7.640

8.  Topical delivery of DNA oligonucleotide to induce p53 generation in the skin via thymidine dinucleotide (pTT)-encapsulated liposomal carrier.

Authors:  Yi-Ping Fang
Journal:  Int J Nanomedicine       Date:  2011-12-20

Review 9.  The role of the EP receptors for prostaglandin E2 in skin and skin cancer.

Authors:  J E Rundhaug; M S Simper; I Surh; S M Fischer
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

10.  The role of optical radiations in skin cancer.

Authors:  Fabrizio Ayala; Marco Palla; Rossella Di Trolio; Nicola Mozzillo; Paolo A Ascierto
Journal:  ISRN Dermatol       Date:  2013-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.